Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
This research trial studies cancer care delivery in adolescent and young adult patients with acute lymphoblastic leukemia. Surveying institutions, evaluating delivery of care at the patient level and seeking input from healthcare providers may help doctors increase rates of adherence to National Comprehensive Cancer Network (NCCN) treatment guidelines. It may also improve care for adolescent and young adult patients with acute lymphoblastic leukemia.
Documentation and Delivery of Guideline-Consistent Treatment in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia (ALL)
- To evaluate the proportion of adolescent and young adult (AYA) acute lymphoblastic leukemia (ALL) patients with a documented treatment plan consistent with NCCN guidelines for AYAs with ALL.
II. To evaluate the proportion of AYA ALL patients whose delivered treatment during induction and post-induction therapy (PIT) is consistent with NCCN guidelines for AYAs with ALL.
III. To determine the impact of treating physician specialty and facility type on likelihood of AYA ALL patients having a documented treatment plan concordant with NCCN guidelines when stratified by age group (15-17year[y], 18-21y, and 22-39y).
IV. To determine the impact of treating physician specialty and facility type on the likelihood of AYA ALL patients receiving induction and post-induction therapy (PIT) concordant with NCCN guidelines when stratified by age group (15-17y, 18-21y, and 22-39y).
- To identify for AYAs with ALL, targetable structure- and process-level barriers and facilitators which will increase the proportion of patients having a documented treatment plan and receiving treatment according to NCCN guidelines.
- To explore potential correlations with clinical and social demographic variables to the presence of a documented treatment plan and delivered treatment consistent with NCCN guidelines in AYAs with ALL.
CHART REVIEW: Patient medical record data is abstracted and treatment plans are reviewed for consistency to NCCN guidelines. For each patient, induction and post-induction care is recorded as either concordant with NCCN guidelines or non-concordant with NCCN guidelines.
SITE QUESTIONNAIRE: Participating sites complete a questionnaire which is designed to capture facility-oriented data.
FOCUS GROUPS: Healthcare providers participate in focus groups over 1-2 hours to discuss facilitators and barriers to AYA ALL guideline concordance. Participants provide responses via electronic handheld technology in order to maintain anonymity followed by discussion of the ideas for clarification.
Acute Lymphoblastic LeukemiaLeukemiaPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, LymphoidMedical Chart ReviewQuestionnaire Administration
You can join if…
Open to people ages 15-39
- Newly diagnosed with either Ph- or Ph+ ALL between January 1st, 2012 and December 31st, 2016
- Both diagnosed and initially treated at the participating National Cancer Institute Community Oncology Research Program (NCORP) institution during induction and post-induction therapy (PIT)
- Aim 3: Healthcare professional currently employed at a participating NCORP institution
- Eligible healthcare providers include but are not limited to: physicians, registered nurses (RNs), nurse practitioners, physician assistants, patient advocates, social workers, pharmacists and clinical research associates (CRAs)
- Aim 3a: Direct involvement in the care of AYA ALL patients
You CAN'T join if...
- Diagnosis of secondary ALL
- Diagnosis of mixed lineage acute leukemia
- Diagnosis of acute leukemia of ambiguous lineage (ALAL)
- Diagnosis of Burkitt?s leukemia
- Transfer of care to another institution during induction or post-induction therapy (PIT)
- Aim 3: Trainee
- Children's Hospital and Research Center at Oaklandaccepting new patients
- Kaiser Permanente-San Franciscoaccepting new patients
San FranciscoCalifornia94115United States
- Kaiser Permanente Cancer Treatment Centeraccepting new patients
South San FranciscoCalifornia94080United States
- Kaiser Permanente-South San Franciscoaccepting new patients
South San FranciscoCalifornia94080United States
- Fresno Cancer Centeraccepting new patients
- Kaiser Permanente-Fresnoaccepting new patients
- accepting new patients
- Start Date
- Completion Date
- Children's Oncology Group
- Study Type
- Last Updated
Please contact me about this study
We will not share your information with anyone other than the team in charge of this study. Submitting your contact information does not obligate you to participate in research.
The study team should get back to you in a few business days.
You will also receive an email with next steps. Check your junk/spam folder if needed.
If you do not hear from the study team, please call 888-689-8273 and tell them you’re interested in study number NCT03204916.